Cargando…

Thrombosis in ovarian cancer: a case control study

BACKGROUND: Thrombotic events are common in cancer patients and have been associated with an adverse prognosis in large registry-based studies. METHODS: A retrospective cohort of 417 patients with ovarian cancer treated at a tertiary cancer centre between 2006 and 2009 was studied to identify the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metcalf, R L, Fry, D J, Swindell, R, McGurk, A, Clamp, A R, Jayson, G C, Hasan, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950877/ https://www.ncbi.nlm.nih.gov/pubmed/24448364 http://dx.doi.org/10.1038/bjc.2014.3

Ejemplares similares

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer
por: Clamp, A R, et al.
Publicado: (2006)

Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers
por: Metcalf, Robert L, et al.
Publicado: (2017)

Antiangiogenic drugs in ovarian cancer
por: Kumaran, G C, et al.
Publicado: (2009)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise
por: McGurk, M, et al.
Publicado: (2003)

A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma
por: Clamp, A R, et al.
Publicado: (2003)

Profiling Heparan Sulfate Proteoglycans in Ovarian Carcinoma
por: Clamp, Andrew R., et al.
Publicado: (2005)

FDG–PET. A possible prognostic factor in head and neck cancer
por: Halfpenny, W, et al.
Publicado: (2002)

Oral melphalan as a treatment for platinum-resistant ovarian cancer
por: Hasan, J, et al.
Publicado: (2003)

A longitudinal investigation of psychological morbidity in patients with ovarian cancer
por: Gonçalves, V, et al.
Publicado: (2008)

Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma
por: Clamp, A R, et al.
Publicado: (2008)

Heparan sulphate synthetic and editing enzymes in ovarian cancer
por: Backen, A C, et al.
Publicado: (2007)

Does clinical trial participation improve outcomes in patients with ovarian cancer?
por: Khoja, L, et al.
Publicado: (2016)

The impact of radiotherapy late effects on quality of life in gynaecological cancer patients
por: Barker, C L, et al.
Publicado: (2009)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Increasing Access to Places for Physical Activity Through a Joint Use Agreement: A Case Study in Urban Honolulu
por: Maddock, Jay, et al.
Publicado: (2008)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

Ecological factors in human development /
por: McGurk, Harry
Publicado: (1977)

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer
por: Morgan, Robert D, et al.
Publicado: (2019)

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage
por: Howell, S J, et al.
Publicado: (2009)

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status
por: Logue, Chloe A., et al.
Publicado: (2021)

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer
por: Hunter, B A, et al.
Publicado: (2014)

Predictors of ovarian reserve in young women with breast cancer
por: Lutchman Singh, K, et al.
Publicado: (2007)

Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study
por: Iles, S M, et al.
Publicado: (2008)

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis
por: Pearce, C L, et al.
Publicado: (2008)

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study
por: Sheikh, H Y, et al.
Publicado: (2007)

Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer
por: Sheikh, H Y, et al.
Publicado: (2008)

The relationship between cognitive functioning, age and employment in people with severe mental illnesses in an urban area in India: A longitudinal study
por: Khare, Chitra, et al.
Publicado: (2022)

Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
por: Wright, J D, et al.
Publicado: (2008)

The clinical potential of antiangiogenic fragments of extracellular matrix proteins
por: Clamp, A R, et al.
Publicado: (2005)

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer
por: Vasey, P A, et al.
Publicado: (2006)

Double insertion of transposable elements provides a substrate for the evolution of satellite DNA
por: McGurk, Michael P., et al.
Publicado: (2018)

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
por: Valle, J W, et al.
Publicado: (2005)

Sialendoscopy-assisted transfacial removal of parotid calculi
por: Hills, A.J., et al.
Publicado: (2017)

Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival
por: Gary, T, et al.
Publicado: (2012)

Ovarian cancer in younger vs older women: a population-based analysis
por: Chan, J K, et al.
Publicado: (2006)

Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)
por: Gollins, S W, et al.
Publicado: (2009)

Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial
por: Dell’ Anna, T, et al.
Publicado: (2012)

Are GPs under-investigating older patients presenting with symptoms of ovarian cancer? Observational study using General Practice Research Database
por: Tate, A R, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uru0s2ur0abddt2f4c5rkukm4u